首页> 美国卫生研究院文献>PLoS ONE >Correction: Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study
【2h】

Correction: Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study

机译:矫正:阿司匹林比氯吡格雷更好地对缺血性卒中后的主要不良心血管事件减少:回顾性全国队列队列研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

After publication of this article [1], the authors contacted PLOS ONE to clarify that they did not obtain prospective institutional review board approval to conduct their study. Upon editorial review and consultation with the Academic Editor, it was determined that the article meets the journal’s standards for ethical oversight and that approval by an ethics committee was not necessary given that all data analyzed in the study were fully anonymized prior to access and analysis by the authors.
机译:在发布本文[1]后,提交人联系了PLOS一个,以澄清他们没有获得预期的机构审查委员会批准以进行学习。根据编辑审查和与学术编辑进行磋商,决定本文符合日志的道德监督标准,并没有必要审批道德委员会的批准,鉴于该研究中分析的所有数据在访问和分析之前完全是匿名的。作者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号